Cargando…

PO-1463 Is irradiation of SARS-CoV-2-positive cancer patients safe and feasible in clinical practice?

Detalles Bibliográficos
Autores principales: Orazem, M., Zumer, B., Segedin, B., Marinko, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ireland Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629147/
http://dx.doi.org/10.1016/S0167-8140(21)07914-7
_version_ 1784607145613852672
author Orazem, M.
Zumer, B.
Segedin, B.
Marinko, T.
author_facet Orazem, M.
Zumer, B.
Segedin, B.
Marinko, T.
author_sort Orazem, M.
collection PubMed
description
format Online
Article
Text
id pubmed-8629147
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Ireland Ltd.
record_format MEDLINE/PubMed
spelling pubmed-86291472021-11-30 PO-1463 Is irradiation of SARS-CoV-2-positive cancer patients safe and feasible in clinical practice? Orazem, M. Zumer, B. Segedin, B. Marinko, T. Radiother Oncol Digital Poster: Health services research/health economics Elsevier Ireland Ltd. 2021-08 2021-09-28 /pmc/articles/PMC8629147/ http://dx.doi.org/10.1016/S0167-8140(21)07914-7 Text en Copyright © 2021 Elsevier Ireland Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Digital Poster: Health services research/health economics
Orazem, M.
Zumer, B.
Segedin, B.
Marinko, T.
PO-1463 Is irradiation of SARS-CoV-2-positive cancer patients safe and feasible in clinical practice?
title PO-1463 Is irradiation of SARS-CoV-2-positive cancer patients safe and feasible in clinical practice?
title_full PO-1463 Is irradiation of SARS-CoV-2-positive cancer patients safe and feasible in clinical practice?
title_fullStr PO-1463 Is irradiation of SARS-CoV-2-positive cancer patients safe and feasible in clinical practice?
title_full_unstemmed PO-1463 Is irradiation of SARS-CoV-2-positive cancer patients safe and feasible in clinical practice?
title_short PO-1463 Is irradiation of SARS-CoV-2-positive cancer patients safe and feasible in clinical practice?
title_sort po-1463 is irradiation of sars-cov-2-positive cancer patients safe and feasible in clinical practice?
topic Digital Poster: Health services research/health economics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629147/
http://dx.doi.org/10.1016/S0167-8140(21)07914-7
work_keys_str_mv AT orazemm po1463isirradiationofsarscov2positivecancerpatientssafeandfeasibleinclinicalpractice
AT zumerb po1463isirradiationofsarscov2positivecancerpatientssafeandfeasibleinclinicalpractice
AT segedinb po1463isirradiationofsarscov2positivecancerpatientssafeandfeasibleinclinicalpractice
AT marinkot po1463isirradiationofsarscov2positivecancerpatientssafeandfeasibleinclinicalpractice